Why GoodRx (GDRX) Stock Is Up Today [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
now offers access to the new higher-dose Wegovy® HD (semaglutide) injection for self-pay patients at a price of $399 per month. This move came amid a growing demand for GLP-1 treatments, a class of drugs that includes Wegovy. GoodRx's initiative simplified access to the popular medication by providing clear pricing that scaled with quantity. A two-month supply was made available for $798, and a three-month supply for $1,197. The effort was seen as a way to provide consumers with flexibility and predictable costs, tapping into the significant self-pay market for these sought-after treatments. After the initial pop the shares cooled down to $2.33, up 4% from previous close. Is now the time to buy GoodRx? Access our full analysis report here, it's free What Is The Market Telling Us GoodRx's shares are extremely volatile and have had 37 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something th
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- Highly contagious stomach bug spreads fast, hitting certain patients hardest [FOX News]FOX News
- Letters to the Editor: When a few buyers control most medications, all consumers suffer [Los Angeles Times (CA)]Los Angeles Times
- GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference CallBusiness Wire
- 3 Reasons GDRX is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- GoodRx vs. CVS vs. Costco: Where Retirees Save the Most on Prescriptions [Yahoo! Finance]Yahoo! Finance
GDRX
Earnings
- 2/25/26 - Beat
GDRX
Sec Filings
- 4/15/26 - Form 4
- 4/15/26 - Form 4
- 4/3/26 - Form 8-K
- GDRX's page on the SEC website